Inserm Transfert (France) and Translational Research Informatics Center (Japan) enter into international cooperation agreement regarding translational researches
Paris, (France), Kobe (Japan), May 7, 2014 – Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), and Translational Research Informatics Center (TRI), in the name of Foundation for Biomedical Research and Innovation (FBRI), committed to promote academic translational researches in Japan, announce today an international cooperation agreement to introduce French biomedicalrelated patents to the Japanese market. Such collaboration will be developed through translational activities which leads to the results from the basic research to the clinical practice and focus on the promotion of the potential license agreements with companies from the Japanese life science industry.
This international alliance marks a significant milestone in strengthening relationships between Inserm Transfert and TRI, two structures from Academia with a prime mission of transferring to the industry for the patients sake. Both stakeholders share the same vision that a comprehensive worldwide eco-system in translational research in the field of biomedical research, is the best way to accelerate the path from scientific achievements to patients.